Terasaki, Michishige
SHOWA Medical University
4 papers on CoChatORCID 0000-0002-7405-7419
Most cited papers
- Verified
Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
Nagashima, M., Watanabe, T., Terasaki, M., Tomoyasu, M., Nohtomi, K., Kim-Kaneyama, J., Miyazaki, A., & Hirano, T. (2011) · Diabetologia
Diabetes Treatment and ManagementAtherosclerosis and Cardiovascular Diseases
Cited by 259
- Verified
A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis
Tashiro, Y., Sato, K., Watanabe, T., Nohtomi, K., Terasaki, M., Nagashima, M., & Hirano, T. (2014) · Peptides
Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases
Cited by 149
- Verified
Glucose-Dependent Insulinotropic Polypeptide Prevents the Progression of Macrophage-Driven Atherosclerosis in Diabetic Apolipoprotein E-Null Mice
Nogi, Y., Nagashima, M., Terasaki, M., Nohtomi, K., Watanabe, T., & Hirano, T. (2012) · PLoS ONE
Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism
Cited by 96
- Verified
The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis
Kushima, H., Mori, Y., Koshibu, M., Hiromura, M., Kohashi, K., Terasaki, M., Fukui, T., & Hirano, T. (2017) · Cardiovascular Diabetology
Nitric Oxide and Endothelin EffectsCoronary Interventions and Diagnostics
Cited by 48
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free